These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Musolesi S Lancet; 1996 Aug; 348(9025):423-8. PubMed ID: 8709780 [TBL] [Abstract][Full Text] [Related]
5. Subtherapeutic oral anticoagulant therapy: frequency and risk factors. Rombouts EK; Rosendaal FR; van der Meer FJ Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419 [TBL] [Abstract][Full Text] [Related]
6. [Gastrointestinal lesions and characteristics of acute gastrointestinal bleeding in acenocoumarol-treated patients]. Nantes Ó; Zozaya JM; Montes R; Hermida J Gastroenterol Hepatol; 2014; 37(6):334-41. PubMed ID: 24582763 [TBL] [Abstract][Full Text] [Related]
7. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases]. Katona A; Márk L Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862 [TBL] [Abstract][Full Text] [Related]
8. [Major closed-space bleeding in patients on anticoagulation with acenocoumarol (TAO) or non-fractionned heparin(HS): a case-control study]. Martínez Lacasa J; Juan N; Juliá J; Rodríguez-Carballeira M; de Diego I; Soto R; Garau J An Med Interna; 2008 Jan; 25(1):9-14. PubMed ID: 18377188 [TBL] [Abstract][Full Text] [Related]
9. Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol. Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Marín F; Lip GYH Clin Ther; 2018 Jan; 40(1):114-122. PubMed ID: 29275065 [TBL] [Abstract][Full Text] [Related]
10. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related]
11. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM). Ansell J; Hollowell J; Pengo V; Martinez-Brotons F; Caro J; Drouet L J Thromb Thrombolysis; 2007 Apr; 23(2):83-91. PubMed ID: 17221328 [TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study. Balsam P; Ozierański K; Tymińska A; Żukowska K; Zaleska M; Szepietowska K; Maciejewski K; Peller M; Grabowski M; Lodziński P; Praska-Ogińska A; Zaboyska I; Kołtowski Ł; Kowalczuk A; Bednarski J; Filipiak KJ; Opolski G Kardiol Pol; 2018; 76(5):889-898. PubMed ID: 29350386 [TBL] [Abstract][Full Text] [Related]
13. Switching from acenocoumarol to warfarin in patients with unstable anticoagulation and its effect on anticoagulation control. Undas A; Cieśla-Dul M; Zółciński M; Tracz W Pol Arch Med Wewn; 2009 Jun; 119(6):360-5. PubMed ID: 19694217 [TBL] [Abstract][Full Text] [Related]
14. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852 [TBL] [Abstract][Full Text] [Related]
16. Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort. Maagdenberg H; Bierings MB; van Ommen CH; van der Meer FJM; Appel IM; Tamminga RYJ; de Boer A; Maitland-van der Zee AH J Thromb Haemost; 2018 Jan; 16(1):116-124. PubMed ID: 29108090 [TBL] [Abstract][Full Text] [Related]
17. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic. Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920 [TBL] [Abstract][Full Text] [Related]
18. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. European Atrial Fibrillation Trial Study Group N Engl J Med; 1995 Jul; 333(1):5-10. PubMed ID: 7776995 [TBL] [Abstract][Full Text] [Related]
19. Risks of oral anticoagulant therapy with increasing age. Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869 [TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulant therapy for heart disease: results in actual cardiology practice. Baggio D; Madore F; Lalonde G Can J Cardiol; 2000 Feb; 16(2):153-61. PubMed ID: 10694585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]